Guided Therapeutics Ships Five LuViva® Advanced Cervical Scans to Chinese Partner Shandong Yaohua

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it has shipped five LuViva devices and associated disposables to Shandong Yaohua Medical Device Technology...

Guided Therapeutics Enters into LuViva® Advanced Cervical Scan Manufacturing and License Agreement for China

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it has reached agreement with Shandong Yaohua Medical Instrument Corporation in China for exclusive...

Guided Therapeutics Announces 1:800 Reverse Stock Split and Elimination of “Toxic” Convertible Securities from its Balance Sheet

Guided Therapeutics, Inc. (OTCQB: GTHP) today announced a one-for-eight hundred (1:800) reverse split of its issued and outstanding common stock. The reverse stock split will be implemented when the market opens on Monday, November 9, 2016 and Guided’s common stock...

Guided Therapeutics Receives Order for 7 LuViva® Advanced Cervical Scans and 4,000 Disposable Cervical Guides for Indonesia

Guided Therapeutics, Inc. (OTCQB: GTHP), developer of the LuViva® Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly and at the point of care, today announced it has received an order for seven additional LuViva® Advanced Cervical...

Guided Therapeutics Reports Second Quarter 2016 Financial Results; Year to Date Revenue Up 71% Over Same Period Last Year

Guided Therapeutics, Inc. (OTCQB: GTHP), developer of the LuViva® Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly and at the point of care, today announced financial results for the second quarter 2016. “We reached a milestone...